We are live on ! Find out more
Dodge & Cox

Dodge & Cox Portfolio holdings

AUM $182B
1-Year Est. Return 14.68%
 

Dodge & Cox, founded in 1930 by Van Duyn Dodge and E. Morris Cox in San Francisco, California, is an independent, employee-owned investment management firm renowned for its disciplined, value-oriented approach to long-term investing. Managing over $350 billion in assets as of late 2024, the firm offers a concise lineup of mutual funds and separate accounts focusing on U.S. and international equities, fixed income, and balanced portfolios, serving individual and institutional investors with a low-turnover, research-driven strategy. Known for its team-based decision-making and contrarian stance—buying undervalued securities others overlook—Dodge & Cox has maintained a consistent philosophy through decades, avoiding trend-chasing and emphasizing fundamentals, even during market volatility like the 2008 crisis. With a tight-knit team of about 300 employees and no proprietary trading, the firm’s commitment to simplicity, low fees, and client alignment has earned it a loyal following and a reputation as a steadfast player in asset management.

This Fund
S&P 500
This Quarter Est. Return
+0.86%
1 Year Est. Return
+14.68%
3 Year Est. Return
+65.98%
5 Year Est. Return
+91.96%
10 Year Est. Return
+336.64%
AUM
$105B
AUM Growth
-$310M
Cap. Flow
-$600M
Cap. Flow %
-0.57%
Top 10 Hldgs %
34.82%
Holding
207
New
40
Increased
53
Reduced
86
Closed
4

Top Sells

Rank Stock Value
1
GSK icon
GSK
GSK
+$1.06B
2
NOK icon
Nokia
NOK
+$561M
3
MHFI
MCGRAW-HILL FINANCIAL INC COM
MHFI
+$511M
4
HPQ icon
HP
HPQ
+$477M
5
DD icon
DuPont de Nemours
DD
+$252M

Sector Composition

Rank Sector Weight
1 Financials 21.16%
2 Technology 20.44%
3 Healthcare 16.97%
4 Communication Services 14.78%
5 Energy 11.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ENZ
201
DELISTED
Enzo Biochem, Inc.
ENZ
$80K ﹤0.01%
+15,570
New +$83.1K
STM icon
202
STMicroelectronics
STM
$47.7B
$79K ﹤0.01%
+10,320
New +$85.9K
NMR icon
203
Nomura Holdings
NMR
$28.6B
$59K ﹤0.01%
+10,000
New +$64.3K
DOX icon
204
Amdocs
DOX
$5.4B
-28,100
Closed -$1.3M
ETN icon
205
Eaton
ETN
$161B
-6,000
Closed -$463K
PBI icon
206
Pitney Bowes
PBI
$2.42B
-48,400
Closed -$1.34M
FRX
207
DELISTED
FOREST LABORATORIES INC
FRX
-45,100
Closed -$4.46M

Similar funds

Dodge & Cox's Q3 2014 Portfolio in Review

As of Q3 2014, Dodge & Cox held 207 positions worth $105B, down 0.3% from $105B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Dodge & Cox's Q3 2014 filing shows 40 new, 53 increased, 86 reduced and 4 closed positions. Its largest new stake was New Oriental: 4,002,900 shares worth $92.9M. The largest sale was GSK, an estimated $1.06B.

By sector, the portfolio is most concentrated in Financials at 21% of assets, up from 21% a quarter earlier, followed by Technology and Healthcare.

  • Dodge & Cox's largest Q3 2014 buy was New Oriental: 4,002,900 shares worth $92.9M.
  • Dodge & Cox added most to eBay in Q3 2014, an estimated $681M increase.
  • Dodge & Cox's biggest Q3 2014 reduction was GSK, cutting an estimated $1.06B.
  • Dodge & Cox fully exited FOREST LABORATORIES INC in Q3 2014, selling an estimated $4.46M.
  • Dodge & Cox's ten largest holdings make up 35% of its $105B portfolio in Q3 2014.
  • Dodge & Cox opened 40 new positions and closed 4 in Q3 2014.
  • Dodge & Cox's portfolio value fell 0.3% quarter-over-quarter to $105B.

Based on Dodge & Cox's 13F filing for Q3 2014, filed 13 Nov 2014.